SGS is pleased to announce the acquisition of Exprimo, NV, based in Mechelen, Belgium.
Exprimo is a European life science consultancy company with strong focus and skills in the application of quantitative, model-based simulations during all stages of pharmaceutical development.
Modelling & Simulations services (M&S) are designed to reduce costs and increase the quality of products and systems therefore highly recommended by the Regulatory Bodies.
Founded in 2002 and privately owned, Exprimo employs 16 highly skilled experts in Belgium, United Kingdom, Sweden, The Netherlands, France and Switzerland. In 2011, they generated revenues in excess of Euro 3 million.
“SGS continues to expand its breadth of services and technologies in our Life Science Services. With this new expertise, we will enhance our service offerings towards existing and potential clients and leverage our network” said Chris Kirk, CEO of SGS.
For further information, please contact:
Jean-Luc de Buman
Communications & IR
1 place des Alpes
CH - 1211 Geneva 1
t: (+41-22) 739 91 11
f: (+41-22) 739 92 00
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 70,000 employees, SGS operates a network of over 1,350 offices and laboratories around the world.